Teradyne Reports First Quarter 2020 Results

• Revenue of $704 million in Q1’20, growth of 43% from Q1’19
• Test revenue grew 50% from Q1’19
• Industrial Automation revenue declined 9% from Q1’19 on global manufacturing weakness
• Share repurchase program suspended as of April 1, 2020            

	Q1'20			Q1'19			Q4'19
Revenue (mil)	$704			$494			$655
GAAP EPS	$0.97			$0.62			$0.69
Non-GAAP EPS	$1.00			$0.54			$0.88

NORTH READING, Mass., April 21, 2020 (GLOBE NEWSWIRE) -- Teradyne, Inc. (NASDAQ: TER) reported revenue of $704 million for the first quarter of 2020 of which $484 million was in Semiconductor Test, $116 million in System Test, $60 million in Industrial Automation (IA) and $43 million in Wireless Test. GAAP net income for the first quarter was $176.2 million or $0.97 per diluted share. On a non-GAAP basis, Teradyne’s net income in the first quarter was $172.5 million, or $1.00 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, non-cash convertible debt interest, discrete tax adjustments and included the related tax impact on non-GAAP adjustments.

“First quarter sales and earnings were in line with our January guidance through the extraordinary efforts of our operations team, their supply line partners, and our customer support teams,” said CEO and President Mark Jagiela. “Production ramps of recent design wins in our System on a Chip and Memory test units continued as planned and the climate in our test businesses remains cautiously positive. However, our Industrial Automation results were below plan as we faced considerable headwinds from the COVID-19 related impacts on global manufacturing activity.

“While test demand remains strong entering the second quarter and our balance sheet has over $900 million in available cash, the impacts of the global pandemic on short term Test and Industrial Automation demand remain uncertain. As a result, we are prudently managing our cash flow and have suspended our share repurchase program until there is more clarity on the economic front. Our second quarter guidance ranges are broader than usual to reflect that demand and supply uncertainty.”

Guidance for the second quarter of 2020 is revenue of $690 million to $800 million, with GAAP net income of $0.76 to $1.05 per diluted share and non-GAAP net income of $0.86 to $1.16 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization, non-cash convertible debt interest and includes the related tax impact on non-GAAP adjustments.

Webcast
A conference call to discuss the first quarter results, along with management's business outlook, will follow at 8:30 a.m. ET, Wednesday, April 22. Interested investors should access the webcast at investors.teradyne.com/events-presentations at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on Teradyne’s Investor Relations site at investors.teradyne.com.

Non-GAAP Results
In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, non-cash convertible debt interest, pension actuarial gains and losses, discrete income tax adjustments, fair value inventory step-up, and restructuring and other, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP gross margin excludes fair value inventory step-up. GAAP requires that this item be included in determining gross margin. Non-GAAP gross margin dollar amount and percentage are non-GAAP performance measures that management believes provide useful supplemental information for management and the investor. Management uses non-GAAP gross margin as a performance measure for Teradyne’s current core business and future outlook and for comparison with Teradyne’s business plan, historical gross margin results and the gross margin results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne
Teradyne (NASDAQ:TER) brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its Industrial Automation offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. In 2019, Teradyne had revenue of $2.3 billion and today employs 5,500 people worldwide. For more information, visit teradyne.com. Teradyne is a registered trademark of Teradyne, Inc. in the U.S. and other countries.

Safe Harbor Statement
This release contains forward-looking statements regarding Teradyne’s future business prospects, the impact of the COVID-19 outbreak, results of operations, market conditions, earnings per share, the payment of a quarterly dividend, the repurchase of Teradyne common stock pursuant to a share repurchase program, and the impact of the U.S. export and tariff laws. Such statements are based on the current assumptions and expectations of Teradyne’s management and are neither promises nor guarantees of future performance, events, earnings per share, use of cash, payment of dividends, repurchases of common stock, payment of the senior convertible notes, the impact of the COVID-19 outbreak, or the impact of the U.S. export and tariff laws. There can be no assurance that management’s estimates of Teradyne’s future results or other forward-looking statements will be achieved. Additionally, the current dividend program may be modified, suspended or discontinued at any time.

On May 16, 2019, Huawei and 68 of its affiliates, including HiSilicon, were added to the U.S. Department of Commerce Entity List under U.S. Export Administration Regulations (the “EAR”). This action by the U.S. Department of Commerce imposed new export licensing requirements on exports, re-exports, and in-country transfers of all U.S. - regulated products, software and technology to the designated Huawei entities.  While most of Teradyne’s products are not subject to the EAR and therefore not affected by the Entity List restrictions, some of its products are currently manufactured in the U.S. and thus subject to the Entity List restrictions. Compliance with the current Entity List restrictions has not significantly impacted Teradyne’s sales. There have been recent news reports that the U.S. Department of Commerce plans to modify the U.S. EAR to expand the scope of the regulations to include additional products that would become subject to the Entity List restrictions relating to Huawei and the designated Huawei entities including HiSilicon. These modified regulations, if implemented as currently reported, may impact Teradyne’s sales to third party contract manufacturers used by Huawei and HiSilicon to manufacture and test semiconductor and other electronic devices. Because the business environment for Huawei is both fluid and uncertain, there are also risks that Huawei, HiSilicon and their third party contract manufacturers may have less demand for Teradyne’s products and/or may purchase products from Teradyne’s competitors who are not impacted by the U.S. regulations. Until these or any new regulations become public and effective, Teradyne will not know the extent of the impact on its business with Huawei, HiSilicon and their third party contract manufacturers. However, it is possible that these modified regulations and any other additional regulations that may be implemented by the U.S. Department of Commerce or other government agency would have a material impact on Teradyne’s business and financial results.

The global outbreak of the recent novel strain of the coronavirus (COVID-19) has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place orders, and shutdowns.  These measures have impacted and may further impact Teradyne’s workforce and operations, the operations of its customers, and those of its contract manufacturers and suppliers.  Teradyne management believes COVID-19 has adversely impacted its results of operations, including increased costs, but cannot accurately estimate the amount of the impact for Teradyne’s first quarter 2020 financial results and to its future financial results. There is considerable uncertainty regarding the impact on Teradyne’s business from the measures in place and potential future measures, and restrictions on Teradyne’s access to its manufacturing facilities or on its support operations or workforce, or similar limitations for its contractor manufacturers and suppliers, and restrictions or disruptions of transportation, such as reduced availability of transportation and increased border controls or closures, could limit Teradyne’s capacity to meet customer demand and have a material adverse effect on its financial condition and results of operations. The COVID-19 outbreak has significantly increased economic and demand uncertainty in Teradyne’s markets. This uncertainty could result in a significant decrease in demand for Teradyne’s products for an uncertain period of time. The spread of COVID-19 has caused Teradyne to modify its business practices (including employee travel, employees working remotely, and cancellation of physical participation in meetings, events and conferences), and the company may take further actions as may be required by government authorities or that it determines are in the best interests of its employees, customers, contract manufacturers and suppliers. There is uncertainty that such measures will be sufficient to mitigate the risks posed by the virus, and Teradyne’s ability to perform critical functions could be harmed. Due to the uncertainty regarding the length, severity and potential business impact of the COVID-19 pandemic, Teradyne has suspended its stock repurchase program. In January 2020, Teradyne announced its intention to repurchase $250 million in shares in 2020. At this time, Teradyne does not know whether or when it will continue its 2020 repurchase plan or authorize future stock repurchase programs. The degree to which COVID-19 impacts Teradyne’s results will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and continued spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.

Important factors that could cause actual results, earnings per share, use of cash, dividend payments, repurchases of common stock, or payment of the senior convertible notes to differ materially from those presently expected include: conditions affecting the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; development, delivery and acceptance of new products; the ability to grow the Industrial Automation business; increased research and development spending; deterioration of Teradyne’s financial condition; the impact of the COVID-19 outbreak and related government responses on the market and demand for Teradyne’s products, on its contract manufacturers and supply chain, and on its workforce; the consummation and success of any mergers or acquisitions; unexpected cash needs; insufficient cash flow to make required payments and pay the principal amount on the senior convertible notes; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in the company’s best interests; additional U.S. tax regulations or IRS guidance; the impact of any tariffs or export controls imposed in the U.S. or China; compliance with trade protection measures or export restrictions; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei and HiSilicon; and other events, factors and risks disclosed in filings with the SEC, including, but not limited to, the “Risk Factors” section of Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019. The forward-looking statements provided by Teradyne in this press release represent management’s views as of the date of this release. Teradyne anticipates that subsequent events and developments may cause management’s views to change. However, while Teradyne may elect to update these forward-looking statements at some point in the future, Teradyne specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Teradyne’s views as of any date subsequent to the date of this release.

TERADYNE, INC. REPORT FOR FIRST FISCAL QUARTER OF 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
						Quarter Ended
						March 29, 2020				December 31, 2019				March 31, 2019
Net revenues						$	704,355			$	654,650			$	494,099
		Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)					298,805				271,412				206,464
Gross profit							405,550				383,238				287,635
Operating expenses:
		Selling and administrative					111,388				117,092				102,013
		Engineering and development					85,159				86,794				76,791
		Acquired intangible assets amortization					9,891				9,784				10,634
		Restructuring and other (2)					(7,606	)			(2,088	)			5,112
		Operating expenses					198,832				211,582				194,550
Income from operations							206,718				171,656				93,085
		Interest and other expense (3)					9,649				22,770				(894	)
Income before income taxes							197,069				148,886				93,979
		Income tax provision (benefit)					20,878				23,811				(15,159	)
Net income						$	176,191			$	125,075			$	109,138
Net income per common share:
Basic						$	1.06			$	0.75			$	0.63
Diluted						$	0.97			$	0.69			$	0.62
Weighted average common shares - basic							166,589				167,286				173,532
Weighted average common shares - diluted (4)							180,736				181,780				176,972
Cash dividend declared per common share						$	0.10			$	0.09			$	0.09
(1	)	Cost of revenues includes:				Quarter Ended
						March 29, 2020				December 31, 2019				March 31, 2019
		Provision for excess and obsolete inventory				$	4,057			$	6,396			$	2,397
		Sale of previously written down inventory					(1,077	)			(1,222	)			(778	)
		Inventory step-up					118				64				-
						$	3,098			$	5,238			$	1,619
(2	)	Restructuring and other consists of:				Quarter Ended
						March 29, 2020				December 31, 2019				March 31, 2019
		Contingent consideration fair value adjustment				$	(10,020	)		$	(2,796	)		$	2,970
		Acquisition related expenses and compensation					1,358				248				1,343
		Employee severance					728				460				799
		Other					328				-				-
						$	(7,606	)		$	(2,088	)		$	5,112
(3	)	Interest and other includes:				Quarter Ended
						March 29, 2020				December 31, 2019				March 31, 2019
		RealWear investment impairment				$	-			$	15,000			$	-
		Non-cash convertible debt interest					3,540				3,496				3,368
		Pension actuarial loss					-				7,727				-
						$	3,540			$	26,223			$	3,368
(4	)	Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, 7.3 million, 7.3 million and 2.2 million shares, respectively, have been included in diluted shares. For the three months ended March 29, 2020, and December 31, 2019, diluted shares also included 5.5 million and 5.4 million shares, respectively, from the convertible note hedge transaction.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
						March 29, 2020				December 31, 2019
Assets
		Cash and cash equivalents				$	593,494			$	773,924
		Marketable securities					211,001				137,303
		Accounts receivable, net					487,365				362,368
		Inventories, net					182,978				196,691
		Prepayments and other current assets					227,740				188,598
		Total current assets					1,702,578				1,658,884
		Property, plant and equipment, net					332,241				320,216
		Operating lease right-of-use assets, net					58,808				57,539
		Marketable securities					100,513				104,490
		Deferred tax assets					74,493				75,185
		Retirement plans assets					18,229				18,457
		Other assets					9,272				10,332
		Acquired intangible assets, net					114,321				125,480
		Goodwill					409,933				416,431
		Total assets				$	2,820,388			$	2,787,014
Liabilities
		Accounts payable				$	129,633			$	126,617
		Accrued employees' compensation and withholdings					119,226				163,883
		Deferred revenue and customer advances					98,815				104,876
		Other accrued liabilities					87,274				70,871
		Operating lease liabilities					19,591				19,476
		Contingent consideration					662				9,106
		Income taxes payable					58,760				44,200
		Total current liabilities					513,961				539,029
		Retirement plans liabilities					125,970				134,471
		Long-term deferred revenue and customer advances					50,791				45,974
		Deferred tax liabilities					11,628				14,070
		Long-term other accrued liabilities					19,941				19,535
		Long-term contingent consideration					19,810				30,599
		Long-term operating lease liabilities					46,328				45,849
		Long-term income taxes payable					82,820				82,642
		Debt					398,466				394,687
		Total liabilities					1,269,715				1,306,856
Shareholders' equity							1,550,673				1,480,158
		Total liabilities and shareholders' equity				$	2,820,388			$	2,787,014
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)
						Quarter Ended
						March 29, 2020				March 31, 2019
Cash flows from operating activities:
		Net income				$	176,191			$	109,138
		Adjustments to reconcile net income to net cash provided by operating activities:
		Depreciation					18,489				16,651
		Amortization					13,391				12,942
		Stock-based compensation					10,460				9,474
		Provision for excess and obsolete inventory					4,057				2,397
		Losses (gains) on investments					4,657				(2,828	)
		Deferred taxes					(1,825	)			1,206
		Contingent consideration fair value adjustment					(10,020	)			2,970
		Other					503				219
		Changes in operating assets and liabilities, net of businesses acquired:
		Accounts receivable					(126,779	)			(41,706	)
		Inventories					15,818				(2,917	)
		Prepayments and other assets					(39,620	)			(18,648	)
		Accounts payable and other liabilities					(35,323	)			(53,323	)
		Deferred revenue and customer advances					(913	)			6,455
		Retirement plans contributions					(1,262	)			(1,210	)
		Income taxes					15,278				(22,804	)
Net cash provided by operating activities							43,102				18,016
Cash flows from investing activities:
		Purchases of property, plant and equipment					(36,700	)			(25,711	)
		Purchases of marketable securities					(187,119	)			(375,184	)
		Proceeds from maturities of marketable securities					98,457				141,201
		Proceeds from sales of marketable securities					15,005				5,440
		Acquisition of businesses, net of cash acquired					149				(6,970	)
		Proceeds from life insurance					-				273
Net cash used for investing activities							(110,208	)			(260,951	)
Cash flows from financing activities:
		Issuance of common stock under stock purchase and stock option plans					12,752				14,268
		Repurchase of common stock					(79,039	)			(156,468	)
		Dividend payments					(16,686	)			(15,627	)
		Payments related to net settlement of employee stock compensation awards					(22,070	)			(14,318	)
		Payments of contingent consideration					(8,852	)			(27,615	)
Net cash used for financing activities							(113,895	)			(199,760	)
Effects of exchange rate changes on cash and cash equivalents							571				(329	)
Decrease in cash and cash equivalents							(180,430	)			(443,024	)
Cash and cash equivalents at beginning of period							773,924				926,752
Cash and cash equivalents at end of period						$	593,494			$	483,728

 

GAAP to Non-GAAP Earnings Reconciliation
(In millions, except per share amounts)
																					Quarter Ended
					March 29, 2020				% of Net Revenues												December 31, 2019				% of Net Revenues											March 31, 2019				% of Net Revenues
Net revenues					$	704.4															$	654.7														$	494.1
Gross profit GAAP and non-GAAP					$	405.6				57.6	%										$	383.2			58.5	%										$	287.6			58.2	%
		Inventory step-up				0.1				0.0	%											0.1			0.0	%											-			-
Gross profit non-GAAP					$	405.7				57.6	%										$	383.3			58.5	%										$	287.6			58.2	%
Income from operations - GAAP					$	206.7				29.3	%										$	171.7			26.2	%										$	93.1			18.8	%
		Acquired intangible assets amortization				9.9				1.4	%											9.8			1.5	%											10.6			2.1	%
		Restructuring and other (1)				(7.6	)			-1.1	%											(2.1	)		-0.3	%											5.1			1.0	%
		Inventory step-up				0.1				0.0	%											0.1			0.0	%											-			-
Income from operations - non-GAAP					$	209.1				29.7	%										$	179.5			27.4	%										$	108.8			22.0	%
													Net Income per Common Share															Net Income per Common Share															Net Income per Common Share
					March 29, 2020				% of Net Revenues				Basic				Diluted				December 31, 2019				% of Net Revenues			Basic				Diluted				March 31, 2019				% of Net Revenues			Basic				Diluted
Net income - GAAP					$	176.2				25.0	%		$	1.06			$	0.97			$	125.1			19.1	%		$	0.75			$	0.69			$	109.1			22.1	%		$	0.63			$	0.62
		Acquired intangible assets amortization				9.9				1.4	%			0.06				0.05				9.8			1.5	%			0.06				0.05				10.6			2.1	%			0.06				0.06
		Interest and other (2)				3.5				0.5	%			0.02				0.02				18.5			2.8	%			0.11				0.10				3.4			0.7	%			0.02				0.02
		Restructuring and other (1)				(7.6	)			-1.1	%			(0.05	)			(0.04	)			(2.1	)		-0.3	%			(0.01	)			(0.01	)			5.1			1.0	%			0.03				0.03
		Pension mark-to-market adjustment (2)				-				-				-				-				7.7			1.2	%			0.05				0.04				-			-				-				-
		Inventory step-up				0.1				0.0	%			0.00				0.00				0.1			0.0	%			0.00				0.00				-			-				-				-
		Exclude discrete tax adjustments (3)				(7.7	)			-1.1	%			(0.05	)			(0.04	)			1.4			0.2	%			0.01				0.01				(30.1	)		-6.1	%			(0.17	)			(0.17	)
		Non-GAAP tax adjustments				(1.9	)			-0.3	%			(0.01	)			(0.01	)			(7.8	)		-1.2	%			(0.05	)			(0.04	)			(3.5	)		-0.7	%			(0.02	)			(0.02	)
		Convertible share adjustment (4)				-				-				-				0.04				-			-				-				0.03				-			-				-				0.01
Net income - non-GAAP (4)					$	172.5				24.5	%		$	1.04			$	1.00			$	152.7			23.3	%		$	0.91			$	0.88			$	94.6			19.1	%		$	0.55			$	0.54
GAAP and non-GAAP weighted average common shares - basic						166.6																167.3															173.5
GAAP weighted average common shares - diluted						180.7																181.8															177.0
		Exclude dilutive shares related to convertible note transaction				(7.3	)															(7.3	)														(2.2	)
Non-GAAP weighted average common shares - diluted						173.4																174.5															174.8
(1	)	Restructuring and other consists of:
					Quarter Ended
					March 29, 2020																December 31, 2019															March 31, 2019
		Contingent consideration fair value adjustment			$	(10.0	)														$	(2.8	)													$	3.0
		Acquisition related expenses and compensation				1.4																0.2															1.3
		Employee severance				0.7																0.5															0.8
		Other				0.3																-															-
					$	(7.6	)														$	(2.1	)													$	5.1
(2	)	For the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, adjustment to exclude non-cash convertible debt interest expense. For the quarter ended December 31, 2019, adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne's mark-to-market pension accounting and adjustment to exclude RealWear $15.0 million investment impairment.
(3	)	For the quarters ended March 29, 2020, December 31, 2019, and March 31, 2019, adjustment to exclude discrete income tax items. For the quarter ended March 31, 2019, income tax (benefit) provision includes a $26 million tax benefit from the release of uncertain tax position reserves due to the IRS completion of its audit of Teradyne's 2015 Federal tax return.
(4	)	For the quarters ended March 29, 2020 and December 31, 2019, the non-GAAP diluted EPS calculation adds back $1.3 million of convertible debt interest expense to non-GAAP net income and non-GAAP weighted average diluted common shares include 5.5 million and 5.4 million shares, respectively, related to the convertible debt hedge transaction.
GAAP to Non-GAAP Reconciliation of Second Quarter 2020 guidance:
GAAP and non-GAAP second quarter revenue guidance:									$690 million			to	$800 million
GAAP net income per diluted share									$	0.76			$	1.05
		Exclude acquired intangible assets amortization								0.06				0.06
		Exclude non-cash convertible debt interest								0.02				0.02
		Tax effect of non-GAAP adjustments								(0.02	)			(0.02	)
		Convertible share adjustment								0.04				0.05
Non-GAAP net income per diluted share									$	0.86			$	1.16
For press releases and other information of interest to investors, please visit Teradyne's homepage at: teradyne.com.
		Contact: Teradyne, Inc.
		Andy Blanchard 978-370-2425
		Vice President of Corporate Relations